GMO Research & AI, Inc. Logo

GMO Research & AI, Inc.

Market research tech providing access to 65M+ APAC consumer panelists for data-driven insights.

3695 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
渋谷区桜丘町26番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

GMO Research & AI, Inc. is a market research technology company specializing in the Asia-Pacific region. Through its Asia Cloud Panel, an online audience engagement platform, the company provides access to over 65 million consumer panelists across 14 APAC markets. As Japan's leading consumer panel provider, GMO Research & AI offers comprehensive sampling solutions for consumer, B2B, and healthcare sectors. The firm leverages deep regional, cultural, and linguistic expertise to deliver reliable, localized data and actionable insights, enabling global clients to make informed, data-driven decisions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 04:59
Report Publication Announcement
確認書
Japanese 9.0 KB
2025-08-13 04:57
Interim Report
半期報告書-第24期(2025/01/01-2025/12/31)
Japanese 254.0 KB
2025-05-19 09:11
Registration Form
臨時報告書
Japanese 35.5 KB
2025-03-19 05:04
Regulatory News Service
臨時報告書
Japanese 29.4 KB
2025-03-19 03:13
Regulatory News Service
確認書
Japanese 9.4 KB
2025-03-19 03:11
Regulatory News Service
内部統制報告書-第23期(2024/01/01-2024/12/31)
Japanese 24.8 KB
2025-03-19 03:09
Annual Report
有価証券報告書-第23期(2024/01/01-2024/12/31)
Japanese 1.3 MB
2025-02-12 07:40
Regulatory News Service
臨時報告書
Japanese 173.9 KB
2024-08-09 06:15
Regulatory News Service
確認書
Japanese 9.4 KB
2024-08-09 06:14
Interim Report
半期報告書-第23期(2024/01/01-2024/12/31)
Japanese 203.1 KB
2024-05-13 04:45
Regulatory News Service
確認書
Japanese 9.5 KB
2024-05-13 04:45
Quarterly Report
四半期報告書-第23期第1四半期(2024/01/01-2024/03/31)
Japanese 160.7 KB
2024-03-19 03:42
Registration Form
確認書
Japanese 8.9 KB
2024-03-19 03:39
Governance Information
内部統制報告書-第22期(2023/01/01-2023/12/31)
Japanese 24.0 KB
2024-03-19 03:37
Registration Form
有価証券報告書-第22期(2023/01/01-2023/12/31)
Japanese 1.3 MB

Automate Your Workflow. Get a real-time feed of all GMO Research & AI, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for GMO Research & AI, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
DT&CRO CO., Ltd. Logo
A full-service CRO for pharma & biotech, from non-clinical studies to FDA approval support.
South Korea 383930
DUSKIN CO.,LTD. Logo
Franchises cleaning rentals and services for homes and businesses, and operates food chains.
Japan 4665
D.Western Therapeutics Institute, Inc. Logo
Biotech firm discovering and licensing drug candidates, focusing on kinase inhibitors.
Japan 4576
ECHOMARKETING Co.,Ltd. Logo
Global agency accelerating sales with data-driven, full-funnel digital marketing.
South Korea 230360
Eezy Oyj Logo
HR services firm for the full employment lifecycle, from recruitment to freelancer support.
Finland EEZY
Enjin Co., Ltd. Logo
PR firm for SMEs and medical institutions, offering consulting and a media matching platform.
Japan 7370
Ensol Biosciences Inc. Logo
Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.
South Korea 140610
Eutilex Co.,Ltd. Logo
Develops T-cell and antibody immunotherapies for cancer and autoimmune diseases.
South Korea 263050
Evogene Ltd. Logo
AI-powered platform designing life-science solutions for health, ag, and industrial sectors.
Israel EVGN
EXACT Therapeutics AS Logo
Biopharma firm using ultrasound to enhance drug delivery for oncology via its ACT® platform.
Norway EXTX

Talk to a Data Expert

Have a question? We'll get back to you promptly.